These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30900179)

  • 21. Utilising Induced Pluripotent Stem Cells in Neurodegenerative Disease Research: Focus on Glia.
    Albert K; Niskanen J; Kälvälä S; Lehtonen Š
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRISPR/Cas9-mediated Knockout of the Neuropsychiatric Risk Gene KCTD13 Causes Developmental Deficits in Human Cortical Neurons Derived from Induced Pluripotent Stem Cells.
    Kizner V; Naujock M; Fischer S; Jäger S; Reich S; Schlotthauer I; Zuckschwerdt K; Geiger T; Hildebrandt T; Lawless N; Macartney T; Dorner-Ciossek C; Gillardon F
    Mol Neurobiol; 2020 Feb; 57(2):616-634. PubMed ID: 31402430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison and optimization of hiPSC forebrain cortical differentiation protocols.
    Muratore CR; Srikanth P; Callahan DG; Young-Pearse TL
    PLoS One; 2014; 9(8):e105807. PubMed ID: 25165848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Rapid Pipeline to Model Rare Neurodevelopmental Disorders with Simultaneous CRISPR/Cas9 Gene Editing.
    Bell S; Peng H; Crapper L; Kolobova I; Maussion G; Vasuta C; Yerko V; Wong TP; Ernst C
    Stem Cells Transl Med; 2017 Mar; 6(3):886-896. PubMed ID: 28170165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted reversion of induced pluripotent stem cells from patients with human cleidocranial dysplasia improves bone regeneration in a rat calvarial bone defect model.
    Saito A; Ooki A; Nakamura T; Onodera S; Hayashi K; Hasegawa D; Okudaira T; Watanabe K; Kato H; Onda T; Watanabe A; Kosaki K; Nishimura K; Ohtaka M; Nakanishi M; Sakamoto T; Yamaguchi A; Sueishi K; Azuma T
    Stem Cell Res Ther; 2018 Jan; 9(1):12. PubMed ID: 29357927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-wide CRISPR/Cas9-knockout in human induced Pluripotent Stem Cell (iPSC)-derived macrophages.
    Navarro-Guerrero E; Tay C; Whalley JP; Cowley SA; Davies B; Knight JC; Ebner D
    Sci Rep; 2021 Feb; 11(1):4245. PubMed ID: 33608581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
    Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
    Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SSEA4-positive pig induced pluripotent stem cells are primed for differentiation into neural cells.
    Yang JY; Mumaw JL; Liu Y; Stice SL; West FD
    Cell Transplant; 2013; 22(6):945-59. PubMed ID: 23043799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reprogramming of HUVECs into induced pluripotent stem cells (HiPSCs), generation and characterization of HiPSC-derived neurons and astrocytes.
    Haile Y; Nakhaei-Nejad M; Boakye PA; Baker G; Smith PA; Murray AG; Giuliani F; Jahroudi N
    PLoS One; 2015; 10(3):e0119617. PubMed ID: 25789622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of induced pluripotent stem cells in regenerative medicine: neurodegenerative diseases.
    Peng J; Zeng X
    Stem Cell Res Ther; 2011 Jul; 2(4):32. PubMed ID: 21861938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stem Cell-Based Disease Modeling and Cell Therapy.
    Bai X
    Cells; 2020 Sep; 9(10):. PubMed ID: 33003295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating Synthetic Activation and Repression of Neuropsychiatric-Related Genes in hiPSC-Derived NPCs, Neurons, and Astrocytes.
    Ho SM; Hartley BJ; Flaherty E; Rajarajan P; Abdelaal R; Obiorah I; Barretto N; Muhammad H; Phatnani HP; Akbarian S; Brennand KJ
    Stem Cell Reports; 2017 Aug; 9(2):615-628. PubMed ID: 28757163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conversion of Human Induced Pluripotent Stem Cells (iPSCs) into Functional Spinal and Cranial Motor Neurons Using PiggyBac Vectors.
    Garone MG; de Turris V; Soloperto A; Brighi C; De Santis R; Pagani F; Di Angelantonio S; Rosa A
    J Vis Exp; 2019 May; (147):. PubMed ID: 31107442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insights into Human-Induced Pluripotent Stem Cell-Derived Astrocytes in Neurodegenerative Disorders.
    Kumar M; Nguyen NTP; Milanese M; Bonanno G
    Biomolecules; 2022 Feb; 12(3):. PubMed ID: 35327542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From Neuronal Differentiation of iPSCs to 3D Neuro-Organoids: Modelling and Therapy of Neurodegenerative Diseases.
    Bordoni M; Rey F; Fantini V; Pansarasa O; Di Giulio AM; Carelli S; Cereda C
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcription Factor-Mediated Generation of Dopaminergic Neurons from Human iPSCs-A Comparison of Methods.
    McDonald KO; Lyons NMA; Gray LKC; Xu JB; Schoderboeck L; Hughes SM; Basak I
    Cells; 2024 Jun; 13(12):. PubMed ID: 38920646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induced pluripotent stem cells (iPSCs) as game-changing tools in the treatment of neurodegenerative disease: Mirage or reality?
    Yousefi N; Abdollahii S; Kouhbanani MAJ; Hassanzadeh A
    J Cell Physiol; 2020 Dec; 235(12):9166-9184. PubMed ID: 32437029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Astrocyte pathology in a human neural stem cell model of frontotemporal dementia caused by mutant TAU protein.
    Hallmann AL; Araúzo-Bravo MJ; Mavrommatis L; Ehrlich M; Röpke A; Brockhaus J; Missler M; Sterneckert J; Schöler HR; Kuhlmann T; Zaehres H; Hargus G
    Sci Rep; 2017 Mar; 7():42991. PubMed ID: 28256506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multi-level characterization of balanced inhibitory-excitatory cortical neuron network derived from human pluripotent stem cells.
    Nadadhur AG; Emperador Melero J; Meijer M; Schut D; Jacobs G; Li KW; Hjorth JJJ; Meredith RM; Toonen RF; Van Kesteren RE; Smit AB; Verhage M; Heine VM
    PLoS One; 2017; 12(6):e0178533. PubMed ID: 28586384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved hematopoietic differentiation efficiency of gene-corrected beta-thalassemia induced pluripotent stem cells by CRISPR/Cas9 system.
    Song B; Fan Y; He W; Zhu D; Niu X; Wang D; Ou Z; Luo M; Sun X
    Stem Cells Dev; 2015 May; 24(9):1053-65. PubMed ID: 25517294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.